Table 2.
Univariate analyses of EOR and RTV outcomes.
| EOR (%) | RTV (cm3) | |||||
|---|---|---|---|---|---|---|
| Dichotomous | N | Group Mean (SEM) | p-value | Group Mean (SEM) | p-value | |
| Age | > 55 | 20 | 89.66 (2.23) | <0.01* | 4.78 (1.09) | <0.01* |
| ≤ 55 | 10 | 97.66 (0.68) | 0.88 (0.39) | |||
| Site | Eloquent | 27 | 91.95 (1.80) | 0.44 | 3.66 (0.89) | 0.40 |
| Non-eloquent | 3 | 95.70 (1.27) | 1.87 (0.54) | |||
| MGMT Promoter | Methylated | 20 | 91.61 (2.13) | 0.53 | 4.30 (1.14) | 0.08 |
| Unmethylated | 10 | 93.78 (1.89) | 1.85 (0.50) | |||
| EGFR | Amplification | 14 | 90.51 (2.77) | 0.32 | 5.18 (1.45) | 0.06 |
| No Amplification | 16 | 93.92 (2.09) | 1.99 (0.78) | |||
| PTEN | Deletion | 25 | 92.09 (1.90) | 0.72 | 3.58 (0.93) | 0.77 |
| Intact | 5 | 93.54 (1.51) | 2.97 (0.80) | |||
| Continuous | N | ρ (SEM) | p-value | ρ (SEM) | p-value | |
|---|---|---|---|---|---|---|
| Age (yrs) | 30 | −0.34 (0.18) | 0.07 | 0.26 (0.18) | 0.17 | |
| SA (mm2) | 30 | −0.08 (0.19) | 0.67 | 0.37 (0.18) | 0.04* | |
| Preoperative Tumor Volume (cm3) | 30 | −0.13 (0.19) | 0.49 | 0.50 (0.16) | <0.01* | |
| NV% (%) | 30 | 0.33 (0.18) | 0.07 | −0.12 (0.19) | 0.52 | |
| SAVR (mm2/cm3) | 30 | 0.26 (0.18) | 0.17 | −0.43 (0.17) | 0.02* | |
*
Significant at p ≤ 0.05.